Clinical Trial Update: Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for boceprevir in chronic hepatitis C genotype 1 nonresponders to peginterferon/ribavirin (P05514) completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2013-11-19